Drug record
What four public record sets show for hydroxyzine. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.029 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $93.0 million | Details |
| FDA recall records | 24 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Hydroxyzine Hcl 10 Mg Tablet: pharmacies pay about $0.029 each, or $0.873 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| HYDROXYZINE 10 MG/5 ML SOLN | Generic | $0.112 per mL | — | Oct 21, 2026 |
| HYDROXYZINE 10 MG/5 ML SYRUP | Generic | $0.112 per mL | — | Oct 21, 2026 |
| HYDROXYZINE HCL 10 MG TABLET | Generic | $0.029 per each | $0.873 | Oct 21, 2026 |
| HYDROXYZINE HCL 25 MG TABLET | Generic | $0.032 per each | $0.973 | Oct 21, 2026 |
| HYDROXYZINE HCL 50 MG TABLET | Generic | $0.054 per each | $1.63 | Oct 21, 2026 |
| HYDROXYZINE PAM 100 MG CAP | Generic | $0.423 per each | $12.69 | Oct 21, 2026 |
| HYDROXYZINE PAM 25 MG CAP | Generic | $0.065 per each | $1.95 | Oct 21, 2026 |
| HYDROXYZINE PAM 50 MG CAP | Generic | $0.081 per each | $2.44 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $93.0 million for the 3 products below. That is up 27% from $73.5 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Hydroxyzine HCl* Hydroxyzine HCl | $73.9 million | 1,459,051 | $15.71 | $50.65 | $59.5 million |
| Hydroxyzine Pamoate Hydroxyzine Pamoate | $19.1 million | 431,543 | $12.08 | $44.18 | $13.9 million |
| Vistaril Hydroxyzine Pamoate | $965 | 44 | $13.78 | $21.93 | $22,531 |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 24 recall records that name hydroxyzine in the product description (20 Class II · 4 Class III). 1 are still marked ongoing.
hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10
Reason: Presence of foreign substance
HydrOXYzine Pamoate Capsules, USP, 50 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0185-0615-01
Reason: cGMP deviations: Temperature abuse
Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDC 60432-150-04, b) 1 pint (473 mL), NDC 60432-150-16, Rx Only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053
Reason: Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.
HydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only, Distributed by Lannett Company, Inc., Philadelphia, PA 19154, NDC 54838-502-80.
Reason: CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.
Hydroxyzine HCl, 50mg/ml Inj, 10ml MDV, Rx, Vital Care Compounder, Hattiesburg, MS
Reason: Lack of Assurance of Sterility
All hydroxyzine Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.
Reason: Lack of Processing Controls
HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL
Reason: Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable
Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc., Amityville, NY, NDC 50383-0796-16
Reason: Failed Impurities/Degradation Specifications
Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) bottle, Rx only, Manufactured for KVK-Tech, Inc., Newtown, PA by Hi-Tech Pharmacal Co., Inc., Amityville, NY, NDC 10702-0052-16
Reason: Failed Impurities/Degradation Specifications
HYDROXYZINE HYDROCHLORIDE (STERILE WATER) (10ML VIAL) 25MG/ML INJECTABLE, Advanced Compounding Pharmacy, 7225 Fulton Ave., North Hollywood, CA 91605
Reason: Lack of Assurance of Sterility
HYDROXYZINE HYDROCHLORIDE (30ML VIAL) (STERILE WATER) 50MG/ML INJECTABLE, Advanced Compounding Pharmacy, 7225 Fulton Ave., North Hollywood, CA 91605
Reason: Lack of Assurance of Sterility
Hydroxyzine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for hydroxyzine. This page is public-record information, not medical advice.